Abbott Laboratories
ABT
$128.54
$0.490.38%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.04% | 7.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.04% | 7.57% | |||
| Cost of Revenue | 4.55% | 8.96% | |||
| Gross Profit | 0.10% | 6.52% | |||
| SG&A Expenses | -1.43% | 1.34% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.46% | 5.42% | |||
| Operating Income | 0.32% | 17.29% | |||
| Income Before Tax | 1.40% | 20.92% | |||
| Income Tax Expenses | 44.47% | -18.10% | |||
| Earnings from Continuing Operations | -7.59% | 34.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.59% | 34.26% | |||
| EBIT | 0.32% | 17.29% | |||
| EBITDA | 0.71% | 13.12% | |||
| EPS Basic | -7.52% | 33.95% | |||
| Normalized Basic EPS | 1.48% | 18.35% | |||
| EPS Diluted | -6.93% | 32.89% | |||
| Normalized Diluted EPS | 1.49% | 18.40% | |||
| Average Basic Shares Outstanding | -0.07% | 0.24% | |||
| Average Diluted Shares Outstanding | -0.08% | 0.21% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.08% | -0.25% | |||